InMode Ltd. Stock

Equities

INMD

IL0011595993

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-05-16 pm EDT 5-day change 1st Jan Change
18.64 USD -1.11% Intraday chart for InMode Ltd. +1.53% -16.19%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 480M Sales 2025 * 520M Capitalization 1.6B
Net income 2024 * 165M Net income 2025 * 189M EV / Sales 2024 * 1.31 x
Net cash position 2024 * 968M Net cash position 2025 * 1.19B EV / Sales 2025 * 0.78 x
P/E ratio 2024 *
9.64 x
P/E ratio 2025 *
8.52 x
Employees 581
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.11%
1 week+1.86%
Current month+8.44%
1 month+5.37%
3 months-21.58%
6 months-15.96%
Current year-16.19%
More quotes
1 week
18.09
Extreme 18.09
19.05
1 month
16.72
Extreme 16.72
19.05
Current year
16.72
Extreme 16.72
26.80
1 year
16.72
Extreme 16.72
48.25
3 years
16.72
Extreme 16.72
99.27
5 years
6.53
Extreme 6.53
99.27
10 years
6.53
Extreme 6.53
99.27
More quotes
Managers TitleAgeSince
Founder 57 08-01-01
Chief Executive Officer 71 08-01-01
Director of Finance/CFO 46 16-12-31
Members of the board TitleAgeSince
Director/Board Member 89 19-08-06
Chief Executive Officer 71 08-01-01
Founder 57 08-01-01
More insiders
Date Price Change Volume
24-05-16 18.64 -1.11% 1,024,607
24-05-15 18.85 +1.45% 1,190,342
24-05-14 18.58 +0.49% 978,212
24-05-13 18.49 +2.15% 937,939
24-05-10 18.1 -1.42% 1,001,694

Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT

More quotes
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.85 USD
Average target price
25.6 USD
Spread / Average Target
+35.81%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW